Skip to search formSkip to main contentSkip to account menu

Angiopep-2

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
One of the major problems facing the treatment of neurological disorders is the poor delivery of therapeutic agents into the… 
2019
2019
Abstract The addition of temozolomide (TMZ) to radiotherapy (RT) improves survival of patients with glioblastoma (GBM). However… 
2018
2018
Abstract Glioma is the most common primary malignant brain tumour and the effect of chemotherapy is hampered by low permeability… 
Highly Cited
2015
Highly Cited
2015
Abstract It is very challenging to treat brain cancer because of the blood–brain barrier (BBB) restricting therapeutic drug or… 
Highly Cited
2014
Highly Cited
2014
A safe and effective therapy for epilepsy requires a drug delivery system that can penetrate the blood-brain barrier and… 
Highly Cited
2014
Highly Cited
2014
The blood-brain barrier (BBB) prevents most drugs from reaching the site of central nervous system (CNS) diseases, intensively… 
Highly Cited
2008
Highly Cited
2008
Paclitaxel is highly efficacious in the treatment of breast, head and neck, non‐small cell lung cancers and ovarian carcinoma… 
Highly Cited
2008
Highly Cited
2008
The blood–brain barrier (BBB) restricts the entry of proteins as well as potential drugs to cerebral tissues. We previously…